Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Total Liabilities

Latest as of December 2025: TL661.10 Million TRY ≈ $14.81 Million USD

Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has total liabilities worth TL661.10 Million TRY (≈ $14.81 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MEDTR cash generation efficiency to assess how effectively this company generates cash.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Total Liabilities Trend (2018–2025)

This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret to evaluate the company's liquid asset resilience ratio.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Liabilities

The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their total liabilities.

Company Country Total Liabilities
Stillwater Critical Minerals Corp
V:PGE
Canada CA$2.18 Million
Patriot One Technologies Inc
F:0PL
Germany €10.94 Million
Evermore Chemical Industry Co Ltd
TW:1735
Taiwan NT$1.65 Billion
Clipan Finance Indonesia Tbk
JK:CFIN
Indonesia Rp4.04 Trillion
Done.ai Group AB
ST:DONE
Sweden Skr297.70 Million
Global View Co Ltd
TW:3040
Taiwan NT$574.45 Million
Sea Oil Public Company Limited
BK:SEAOIL
Thailand ฿1.64 Billion
Future Vision II Acquisition Corporation Ordinary shares
NASDAQ:FVN
USA $202.33K

Liability Composition Analysis (2018–2025)

This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)

The table below shows the annual total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 TL661.10 Million
≈ $14.81 Million
-12.18%
2024-12-31 TL752.75 Million
≈ $16.86 Million
+26.19%
2023-12-31 TL596.54 Million
≈ $13.36 Million
+180.84%
2022-12-31 TL212.41 Million
≈ $4.76 Million
+41.76%
2021-12-31 TL149.84 Million
≈ $3.36 Million
+20.32%
2020-12-31 TL124.53 Million
≈ $2.79 Million
+32.87%
2019-12-31 TL93.72 Million
≈ $2.10 Million
-1.71%
2018-12-31 TL95.36 Million
≈ $2.14 Million
--

About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

IS:MEDTR Turkey Medical Devices
Market Cap
$80.76 Million
TL3.61 Billion TRY
Market Cap Rank
#20028 Global
#311 in Turkey
Share Price
TL30.30
Change (1 day)
+1.00%
52-Week Range
TL25.62 - TL37.54
All Time High
TL52.90
About

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more